Targeted Empower providers should have recently received the 2025 Satisfaction Survey information via email and snail mail. Click here for more information.

HAEMOPHILUS INFLUENZAE TYPE B VACCINE (HIB), PRP-OMP CONJUGATE, 3 DOSE SCHEDULE, FOR INTRAMUSCULAR USE

Powered by Lapero